Home › Drug Codes › J Codes › J1811 · FIASP
Updated October 1st, 2026

FIASP J Code: J1811

Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units

Login to unlock all benchmarks
Medicare Payment Limit ?
$1.181
/ HCPCS billing unit
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →
Self-Administered Drug Exclusion 7 Medicare Administrative Contractors list J1811 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: CGS, First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
HCPCS Added Date July 1, 2023
Manufacturer Novo Nordisk
Route of Administration Subcutaneous
Generic Status Single-Source; Branded
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection, Solution

About FIASP

Fiasp is a medication aligned to the HCPCS J Code: J1811 for billing, pricing, and reimbursement purposes in the United States. Classified under Insulin, it is administered via the subcutaneous route and manufactured by Novo Nordisk.

According to CMS Drug Use Information: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00169-3201-11 Fiasp Novo Nordisk 20 Fiasp Subcutaneous Inj ection 1000 UNIT… Login for More
00169-3206-15 Fiasp Novo Nordisk 16 Fiasp Subcutaneous Inj ection 160 UNIT/… Login for More
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

FIASP Pricing & Reimbursement

J1811 Private Payer Reimbursement
$7.77 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Insulin 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J1811 Novo Nordisk Insulin Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812 Novo Nordisk Insulin Insulin (fiasp), per 5 units
J1813 Generic Code (Multiple Manufacturers) Insulin Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814 Eli Lilly Insulin Insulin (lyumjev), per 5 units

FIASP CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

CMS does not include Fiasp (J1811) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1811. Wastage billing guide →

FIASP Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

diabetes mellitus
Drug Class
Insulin Analog [EPC]Insulin [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Fiasp billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for FIASP.
Are there any available Fiasp patient assistance programs?
FIASP patient assistance information can be found through NOVO NORDISK INC. Visit Here →
Where can I find Fiasp prescribing information?
FIASP prescribing information can be found at the link below: Visit Here →
Where can I find Fiasp side effect information?
Information regarding FIASP's side effects can be found at MedlinePlus Visit Here →
Does billing FIASP require JZ/JW wastage modifiers?
CMS does not include FIASP (J1811) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1811. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.